WallStSmart

Lineage, Inc. Common Stock (LINE)vsVornado Realty Trust (VNO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 189% more annual revenue ($5.36B vs $1.85B). VNO leads profitability with a 42.9% profit margin vs -2.7%. VNO earns a higher WallStSmart Score of 61/100 (C+).

LINE

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 5.0Quality: 3.0
Piotroski: 2/9Altman Z: 0.67

VNO

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 6.5Value: 8.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.61
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LINE.

VNOUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$45.30

Current Price

$40.65

$4.65 discount

UndervaluedFair: $45.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

VNO4 strengths · Avg: 9.5/10
P/E RatioValuation
10.9x10/10

Attractively priced relative to earnings

Profit MarginProfitability
42.9%10/10

Keeps 43 of every $100 in revenue as profit

EPS GrowthGrowth
1263.0%10/10

Earnings expanding 1263.0% YoY

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

LINE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.4%4/10

0.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

Debt/EquityHealth
1.013/10

Elevated debt levels

VNO4 concerns · Avg: 2.8/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Debt/EquityHealth
1.403/10

Elevated debt levels

Revenue GrowthGrowth
-2.2%2/10

Revenue declined 2.2%

Altman Z-ScoreHealth
0.612/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : VNO

The strongest argument for VNO centers on P/E Ratio, Profit Margin, EPS Growth. Profitability is solid with margins at 42.9% and operating margin at 13.7%.

Bear Case : LINE

The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.

Bear Case : VNO

The primary concerns for VNO are PEG Ratio, Debt/Equity, Revenue Growth.

Key Dynamics to Monitor

LINE profiles as a turnaround stock while VNO is a declining play — different risk/reward profiles.

LINE is growing revenue faster at 0.4% — sustainability is the question.

VNO generates stronger free cash flow (48M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

VNO scores higher overall (61/100 vs 34/100), backed by strong 42.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.

Visit Website →

Vornado Realty Trust

REAL ESTATE · REIT - OFFICE · USA

Vornado Realty Trust is a real estate investment trust formed in Maryland, with its primary office in New York City. The company invests in office buildings and street retail in Manhattan.

Want to dig deeper into these stocks?